579
Participants
Start Date
January 31, 2002
Primary Completion Date
March 31, 2003
Study Completion Date
March 31, 2003
Metronidazole
Vaginal Gel, 0.75%
Metronidazole
Vaginal Gel, 0.75%
Kings County Hospital Center, Brooklyn
SUNY Downstate Medical Center, Brooklyn
Elite Medical Research, Inc., Sellersville
Stonebridge OB/GYN Associates, Sellersville
Philadelphia Women's Research, Philadelphia
Office of Drs. Shepard and Lugerner, PC, Washington D.C.
Women's Health Associates, PC, Fairfax
Office of H. Sharon Sethi, Fairfax
Millennium Clinical Research Center, LLC, Arlington
MedSource, Inc., Richmond
Office of Max S. Maizels, MD, Richmond
Office of Prescott W. Prillaman, MD, PC, Richmond
Chapel Hill Obstetrics and Gynecology, PA, Chapel Hill
Cooperfield Obstetrics and Gynecology, LLC, Concord
Anderson Family Care, Anderson
Carolina OB/GYN, Anderson
Primary Care Associates, Anderson
Radiant Research, Anderson
KGR, LLC, Riverdale
Florida Medical and Research Institute, PA, Gainesville
Meadowcrest Women's Center, Crystal River
The Florida Wellcare Alliance, LC, Inverness
Wellness Center for Gyn & Osteoporosis, Inverness
Florida Medical and Research Institute, PA, Ocala
Clinic for Women, PA, Huntsville
Medical Affiliated Research Center, Inc., Huntsville
Research Memphis, Memphis
Central Kentucky Research Associates, Inc., Lexington
Women's Health Practice, Champaign
New Orleans Institute of Clinical Investigation, New Orleans
O.U. Physicians' Building, Oklahoma City
The OU Medical Center, Oklahoma City
University of Oklahoma Health Services Center, Oklahoma City
Edinger Medical Group, Fountain Valley
Medford Women's Clinic, Medford
Phoenix Ob-Gyn Associated, Moorestown
Phoenix Ob-Gyn Associates, Mount Holly
Teva Pharmaceuticals USA
INDUSTRY